Correlation Between India Globalization and MAIA Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both India Globalization and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining India Globalization and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between India Globalization Capital and MAIA Biotechnology, you can compare the effects of market volatilities on India Globalization and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in India Globalization with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of India Globalization and MAIA Biotechnology.

Diversification Opportunities for India Globalization and MAIA Biotechnology

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between India and MAIA is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding India Globalization Capital and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and India Globalization is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on India Globalization Capital are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of India Globalization i.e., India Globalization and MAIA Biotechnology go up and down completely randomly.

Pair Corralation between India Globalization and MAIA Biotechnology

Considering the 90-day investment horizon India Globalization Capital is expected to generate 0.8 times more return on investment than MAIA Biotechnology. However, India Globalization Capital is 1.25 times less risky than MAIA Biotechnology. It trades about 0.02 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about 0.01 per unit of risk. If you would invest  40.00  in India Globalization Capital on October 12, 2024 and sell it today you would lose (5.00) from holding India Globalization Capital or give up 12.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

India Globalization Capital  vs.  MAIA Biotechnology

 Performance 
       Timeline  
India Globalization 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days India Globalization Capital has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
MAIA Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MAIA Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong forward indicators, MAIA Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

India Globalization and MAIA Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with India Globalization and MAIA Biotechnology

The main advantage of trading using opposite India Globalization and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if India Globalization position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.
The idea behind India Globalization Capital and MAIA Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios